Chemours Valuation
| CC Stock | USD 15.80 0.35 2.17% |
At this time, the firm appears to be undervalued. Chemours shows a prevailing Real Value of $17.93 per share. The current price of the firm is $15.8. Our model approximates the value of Chemours from analyzing the firm fundamentals such as profit margin of 0.01 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Chemours' valuation include:
Undervalued
Today
Please note that Chemours' price fluctuation is not too volatile at this time. Calculation of the real value of Chemours is based on 3 months time horizon. Increasing Chemours' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chemours is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemours Stock. However, Chemours' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.8 | Real 17.93 | Target 24.22 | Hype 15.11 | Naive 16.59 |
The real value of Chemours Stock, also known as its intrinsic value, is the underlying worth of Chemours Company, which is reflected in its stock price. It is based on Chemours' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chemours' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chemours Co helps investors to forecast how Chemours stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemours more accurately as focusing exclusively on Chemours' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Chemours' intrinsic value based on its ongoing forecasts of Chemours' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Chemours' closest peers. If more than one evaluation category is relevant for Chemours we suggest using both methods to arrive at a better estimate.
Chemours Cash |
|
Chemours Valuation Trend
Comparing Chemours' enterprise value against its market capitalization is a good way to estimate the value of Chemours Co uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Chemours Revenue by Product
Chemours Total Value Analysis
Chemours Co is currently forecasted to have takeover value of 6.15 B with market capitalization of 2.5 B, debt of 4.36 B, and cash on hands of 1.1 B. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Chemours fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.15 B | 2.5 B | 4.36 B | 1.1 B |
Chemours Investor Information
About 86.0% of the company shares are held by institutions such as insurance companies. The book value of Chemours was currently reported as 4.04. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Chemours last dividend was issued on the 28th of February 2025. Based on the key indicators related to Chemours' liquidity, profitability, solvency, and operating efficiency, Chemours Co may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Chemours Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemours has an asset utilization ratio of 76.94 percent. This indicates that the Company is making $0.77 for each dollar of assets. An increasing asset utilization means that Chemours Co is more efficient with each dollar of assets it utilizes for everyday operations.Chemours Ownership Allocation
Chemours holds a total of 149.44 Million outstanding shares. The majority of Chemours Co outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of Chemours Co as this could imply that something significant has changed or is about to change at the company. On November 7, 2017, Senator Tammy Duckworth of US Senate acquired under $15k worth of Chemours's common stock.Chemours Profitability Analysis
The company generated the yearly revenue of 5.78 B. Reported Net Income was 86 M with gross profit of 1.15 B.Chemours Past Distributions to stockholders
| 16th of December 2024 | ||
| 13th of September 2024 | ||
| 14th of June 2024 | ||
| 15th of March 2024 | ||
| 15th of December 2023 | ||
| 15th of September 2023 | ||
| 15th of June 2023 | ||
| 15th of March 2023 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chemours' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chemours and how it compares across the competition.
About Chemours Valuation
The stock valuation mechanism determines Chemours' current worth on a weekly basis. Our valuation model uses a comparative analysis of Chemours. We calculate exposure to Chemours's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chemours's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.2 B | 1.2 B | |
| Pretax Profit Margin | 0.02 | 0.02 | |
| Operating Profit Margin | 0.08 | 0.11 | |
| Net Profit Margin | 0.01 | 0.01 | |
| Gross Profit Margin | 0.20 | 0.26 |
A single share of Chemours represents a small ownership stake in the entity. As a stockholder of Chemours, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Chemours Dividends Analysis For Valuation
The current year's Dividend Payout Ratio is expected to grow to 1.81, whereas Dividends Paid is forecasted to decline to about 134.5 M. . At present, Chemours' Price Earnings Ratio is projected to decrease significantly based on the last few years of reporting.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 148 M | 134.5 M | |
| Dividend Yield | 0.06 | 0.04 | |
| Dividend Payout Ratio | 1.72 | 1.81 | |
| Dividend Paid And Capex Coverage Ratio | (1.25) | (1.18) |
There are various types of dividends Chemours can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Chemours shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Chemours Co directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Chemours pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Chemours by the value of the dividends paid out.
Chemours Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 150 M | |
| Quarterly Earnings Growth Y O Y | -0.646 | |
| Forward Price Earnings | 8.058 |
Chemours Current Valuation Indicators
Valuation refers to the process of determining the present value of Chemours Co and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Chemours we look at many different elements of the entity such as Chemours's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Chemours, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Chemours' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Chemours' worth.Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |